Total Funding
93
91
Total FundingGrant raised
Growth Score
23 pts
Heat Score
50 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4095
4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
- Craig Benson: Founder & CEOPast Role: Rules-Based Medicine, Owner, President & Chief Executive Officer
Joe Price: Co-Founder & Chairman ,PresidentPast Role: Blackbaud, Sr. Operations Officer
Eli Lilly
About the Company
4E Therapeutics is developing an innovative therapy for chronic neuropathic pain and is also at the forefront of discovering and developing compounds to treat migraine and acute pain. Neuropathic pain is a serious unmet medical need. They make an effort to regulate the activity of pain-sensing neurons in the peripheral nervous system.
